Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma
Condition(s):Pancreatic AdenocarcinomaLast Updated:October 2, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Pancreatic AdenocarcinomaLast Updated:October 2, 2019Completed
Condition(s):Metastatic Pancreatic AdenocarcinomaLast Updated:December 31, 2020Completed
Condition(s):Pancreatic AdenocarcinomaLast Updated:December 19, 2017Completed
Condition(s):Pancreatic Adenocarcinoma; Pancreatic Cancer Non-resectableLast Updated:July 19, 2023Recruiting
Condition(s):Pancreatic AdenocarcinomaLast Updated:September 22, 2023Recruiting
Condition(s):Locally Advanced Unresectable Pancreatic AdenocarcinomaLast Updated:July 10, 2023Completed
Condition(s):Metastatic Pancreatic AdenocarcinomaLast Updated:October 3, 2023Completed
Condition(s):Pancreatic AdenocarcinomaLast Updated:October 23, 2023Active, not recruiting
Condition(s):Pancreatic AdenocarcinomaLast Updated:November 22, 2023Completed
Condition(s):Pancreatic AdenocarcinomaLast Updated:November 18, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.